Reg Med - Wake Forest / Breaking News !

PHI`s nära kompis Wake Forest Institute for Regenerativ Medicin (WFIRM) har tagit hem 400 Msek från den amerikanska arméns hälsodepartement.Det i syfte att ta fram Reg Med-relaterad sjukvård för amerikanska militärer. Det är lite oklart om beloppet är 1x400 Msek eller 5x400 Msek. 

"WFIRM has been selected to lead the Armed Forces Institute of Regenerative Medicine (AFIRM) Consortium - a $40 million, five year-long award from the Defense Health Agency (DHA)."

Defense Health Agency beskriver sin verksamhet enligt följande : 

The Military Health System is one of America’s largest and most complex health care institutions, and the world’s preeminent military health care delivery operation. Our MHS saves lives on the battlefield, combats infectious disease around the world, and is responsible for providing health services through both 

Click to closeDirect CareDirect care refers to military hospitals and clinics, also known as “military treatment facilities” and “MTFs.”direct care and Click to closeprivate sector careNetwork and non-network TRICARE-authorized civilian health care professionals, pharmacies, and suppliers.private sector care to approximately 9.6 million beneficiaries, composed of uniformed service members, military retirees, and family members.

The MHS enables the National Defense Strategygoes to the Defense.gov website by providing a Medically Ready Force, a Ready Medical Force, and improving the health of all those entrusted to its care. We are more than combat medicine. The MHS is a complex system that weaves together...

• Health care delivery
• Medical education
• Public health
• Private sector partnerships
• Cutting edge medical research and development

Our Mission

The missions of the MHS are complex and interrelated:

• To ensure America’s active duty and reserve-component personnel are healthy so they can complete their national security missions.
• To ensure that all active and reserve medical personnel in uniform are trained and ready to provide medical care in support of operational forces around the world.
• To provide a medical benefit commensurate with the service and sacrifice of more than 9.6 million active duty personnel, military retirees and their families. 

Wake Forest Institute for Regenerative Medicine (WFIRM) to lead $40 Million initiative for AFIRM Consortium

Winston Salem, NC – January 22, 2024 - The Wake Forest Institute for Regenerative Medicine, part of Wake Forest University School of Medicine, has been selected to lead the Armed Forces Institute of Regenerative Medicine (AFIRM) Consortium. The project - a $40 million, five year-long award from the Defense Health Agency (DHA) - will focus on taking regenerative medicine solutions for battlefield injuries to the next level, and ultimately to the general public.

Regenerative medicine is a science that takes advantage of the body's natural abilities to restore or replace damaged tissue and organs. WFIRM has managed two prior AFIRM consortia since 2008 that resulted in over 20 clinical studies for innovative regenerative medicine therapies, including new treatments for burns and limb, genitourinary, facial and skull injuries.

This 2023 initiative by the US Army Medical Research and Development Command (MRDC) and Medical Technology Enterprise Consortium (MTEC) will renew efforts from previous projects while bringing original ideas and the latest technologies to the research. The goal is to bring measurable acceleration to clinical products through robust partnerships.

The team will focus on developing clinical therapies over the next 5 years in the areas of:

• Craniofacial regeneration
• Extremity regeneration
• Genitourinary/lower abdomen
• Skin and wound healing
• On-demand blood
• Cellular therapies for trauma

“The consortium is composed of partners from academia and industry. We look forward to meeting the goal of the new AFIRM to accelerate the transition of regenerative medicine solutions into clinical use, and to improve the lives of our wounded service members, veterans, and the American public,” said Anthony Atala, M.D., lead investigator for AFIRM and director of the Wake Forest Institute for Regenerative Medicine.

“Regenerative medicine therapies are not just treatments, but a lifeline for our military’s healthcare future. Through the leadership of AFIRM and the expertise of the Combat Casualty Care Team, we will build a better experience for those who have devoted their lives to our nation,” stated Captain Travis M. Polk, MD, FACS, Director for the U.S. Army Medical Research and Development Command’s Combat Casualty Care Research Program.

“All AFIRM projects are ‘results-focused,’ not only funding scientific research but requiring that discoveries be tested and compared so that the most promising can be brought to clinical trials,” explained William Wagner, Ph.D., co-director for AFIRM and professor of bioengineering at the University of Pittsburgh. The University of Pittsburgh is a partner on the grant.

MTEC is a non-profit partnership of international biomedical technology companies collaborating with multiple government agencies, working with MRDC under the Other Transactions Authority (OTA). WFIRM, MTEC, and MRDC will be bringing together Regenerative Medicine research and clinical studies to provide new products and healing therapies for U.S. military personnel and civilians.

En kommentar från Linkedin : What a sense of pride I felt yesterday as Dr. Atala made his remarks about this amazing award to the Wake Forest Institute for Regenerative Medicine:

“For us, that’s a higher calling – there is no one that’s more deserving of these technologies than those that have put their lives at risk and sacrificed themselves for our nation”

Echoing Dr. Atala’s comments, and Dean Boulware’s sentiments as this exciting initiative kicks off, which will work towards creating novel technologies for extremity regeneration, cranio-facial regeneration, wound healing, and even on-demand blood for our soldiers and wounded combat veterans.

Min kommentar
1. Kopplingen Military Health System och Veterans Affair känns ganska tydlig.
2. Att vår kompis Anthony Atala kommer leda detta joint venture berättar att den amerikanska Reg Med sektorn står inför en ny fas.

3. Det är absolut rimligt att tro att med denna utmärkelse kommer Atala accelerera all den Reg Med-verksamhet han är involverad i,ink ReMDO. Det i sin tur innebär mest logiskt att HoloMonitor kommer att användas i "skarpt läge" där instrumentet är installerat. Konsekvens av det är att HoloMonitor får ett snabbspår till att bevisa sin användbarhet och hur central den är för Reg Med. Ökad intensitet i Atalas Reg Med verksamhet kan även innebära fler inköp av HoloMonitor. Förhandstips är att Military Health Systems och ev Veterans Affair i så fall kommer stå som köpare. Det utöver ev de andra Atala-kopplade verksamheterna.

4. OBS!. Denna utmärkelse är INTE den på 1,6 Miljarder Skr NSF utlyst. Däremot kan den ge en indikation på vilken vinnare NSF har tänkt kora som vinnare.

5. Vi kan konstatera att Reg Med är stekhett och att jänkarna som vanligt tar tätpositionen.

                                                   Happy Days Are Coming

                                              Mvh the99